| Literature DB >> 30917314 |
Shanti Souriant1, Luciana Balboa2, Maeva Dupont1, Karine Pingris3, Denise Kviatcovsky2, Céline Cougoule1, Claire Lastrucci4, Aicha Bah3, Romain Gasser5, Renaud Poincloux3, Brigitte Raynaud-Messina3, Talal Al Saati6, Sandra Inwentarz7, Susana Poggi7, Eduardo Jose Moraña7, Pablo González-Montaner7, Marcelo Corti8, Bernard Lagane5, Isabelle Vergne3, Carolina Allers9, Deepak Kaushal9, Marcelo J Kuroda9, Maria Del Carmen Sasiain2, Olivier Neyrolles1, Isabelle Maridonneau-Parini1, Geanncarlo Lugo-Villarino10, Christel Vérollet11.
Abstract
The tuberculosis (TB) bacillus, Mycobacterium tuberculosis (Mtb), and HIV-1 act synergistically; however, the mechanisms by which Mtb exacerbates HIV-1 pathogenesis are not well known. Using in vitro and ex vivo cell culture systems, we show that human M(IL-10) anti-inflammatory macrophages, present in TB-associated microenvironment, produce high levels of HIV-1. In vivo, M(IL-10) macrophages are expanded in lungs of co-infected non-human primates, which correlates with disease severity. Furthermore, HIV-1/Mtb co-infected patients display an accumulation of M(IL-10) macrophage markers (soluble CD163 and MerTK). These M(IL-10) macrophages form direct cell-to-cell bridges, which we identified as tunneling nanotubes (TNTs) involved in viral transfer. TNT formation requires the IL-10/STAT3 signaling pathway, and targeted inhibition of TNTs substantially reduces the enhancement of HIV-1 cell-to-cell transfer and overproduction in M(IL-10) macrophages. Our study reveals that TNTs facilitate viral transfer and amplification, thereby promoting TNT formation as a mechanism to be explored in TB/AIDS potential therapeutics.Entities:
Keywords: AIDS; HIV-1; IL-10; Mycobacterium tuberculosis; STAT3; biomarker; co-infection; macrophage; monocyte; tuberculosis; tunneling nanotubes; viral spread
Mesh:
Substances:
Year: 2019 PMID: 30917314 PMCID: PMC6733268 DOI: 10.1016/j.celrep.2019.02.091
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423